Prime

Trials on drugs for resistant TB begin

TBA-7371 is being developed by TB Alliance in collaboration with AstraZeneca, a global biopharmaceutical company. PHOTO FILE | NATION

By  ANGELA OKETCH

Trials on two new tuberculosis antibiotics — TBA-7371 and Sutezolid — have begun, coming at a time when drug resistance is on the rise.

The trials are being conducted in Mexico by the Global Alliance for TB Drug Development.

Be the First to Know

Get the stories shaping East Africa — delivered straight to your inbox

Conflict

  1. PRIME How Houthis are restructuring Somali politics

  2. PRIME A regional war: Ethiopia troop pullout plan puts Somalia security under new strain

  3. Explainer: Why new war in Ethiopia’s Tigray threatens to trigger wider conflict

  4. PRIME Ethiopia, Sudan junta bicker again over RSF support claims

Latest

  1. Why US midterms could decide fate of Somali-Americans

  2. PRIME How Houthis are restructuring Somali politics

  3. Congo's ex-president Kabila forms new group to replace M23 insurgency

  4. Immigration authorities raid home of Ilhan Omar

In the headlines

View All